Weight-Loss drug may also protect heart arteries

NCT ID NCT07657676

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether mazdutide, a weekly injection that helps with weight loss, can slow the buildup of fatty plaque in the heart arteries of 116 overweight or obese adults with coronary heart disease. Participants will receive either the drug or a placebo for 52 weeks, and doctors will use CT scans to measure changes in plaque and inflammation. The goal is to see if this drug can do more than just help with weight—it might also protect the heart.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mazdutide (a weekly injection that targets gut hormones to help with weight and metabolism)
What this could lead to
If it works, this could point toward a treatment that slows heart disease progression in people who are overweight.
What could go wrong
This is a small, early-phase trial with only 116 participants, so results may not apply widely. The drug may not reduce plaque or could cause side effects like nausea or injection-site reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary atherosclerosis Coronary Disease Obesity obesity disorder Overweight Plaque, Amyloid

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

    Beijing, Beijing Municipality, 100037, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.